<div><div></div><div><span><p><strong><span>Profusa requested Ascent Partners Fund to purchase shares under their equity line with new pricing and true-up terms.</span></strong></p><p><strong><span>Key Highlights:</span></strong></p><ul><li><span>Submitted Advance Notice asking Ascent to buy up to 9.99% of outstanding shares per notice, capped at $300,000.</span></li><li><span>Purchase price funded upon delivery of shares; Ascent remits within one trading day 97% of the lowest 10-day VWAP times shares.</span></li><li><span>Includes a True-Up Mechanism: if 97% of the lowest VWAP during the Adjustment Period is below the closing price, Profusa will issue additional shares so Ascent receives the equivalent number.</span></li></ul><p><span>Original SEC Filing: </span>Profusa, Inc. [ PFSA ] - 8-K - May. 18, 2026</p><section><b><span class="heading-JaE7wgR2">Disclaimer</span></b><div><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>

PFSA

LABU

SBIO

<p>Profusa has submitted an advance notice to Ascent Partners Fund for the purchase of up to 9.99% of its outstanding shares, capped at $300,000. The purchase price will be based on 97% of the lowest 10-day VWAP, with a true-up mechanism to issue additional shares if necessary. This is part of their equity line agreement.</p>

TradingView

Profusa

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

PROFUSA INC. C/WTS 02/08/2027 (TO PUR COM)

Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism